Inventor · disambiguated record
Emmanuel John Simons
Also filed as: SIMONS EMMANUEL J · SIMONS EMMANUEL JOHN
15 granted patents·24 pending applications·66 citations·filing 2009–2025
92Inventor score
Top patents by PatentIndex Score
39 records- 0197US11807867B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2022·Granted Nov 7, 2023·13 cites·28 claims
- 0296US12077773B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2023·Granted Sep 3, 2024·5 cites·25 claims
- 0395US12077783B2AAV-mediated delivery of antibodies to the inner earAKOUOS INC·Filed 2022·Granted Sep 3, 2024·2 cites·16 claims
- 0495US12071627B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2023·Granted Aug 27, 2024·3 cites·26 claims
- 0595US11781145B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2022·Granted Oct 10, 2023·9 cites·29 claims
- 0695US11697801B2AAV-mediated delivery of therapeutic antibodies to the inner earAKOUOS INC·Filed 2021·Granted Jul 11, 2023·3 cites·25 claims
- 0795US11525139B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2021·Granted Dec 13, 2022·15 cites·25 claims
- 0894US12275960B2AAV-mediated delivery of therapeutic antibodies to the inner earAKOUOS INC·Filed 2023·Granted Apr 15, 2025·1 cites·15 claims
- 0994US11993777B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2023·Granted May 28, 2024·3 cites·29 claims
- 1090US12264317B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2024·Granted Apr 1, 2025·0 cites·30 claims
- 1188US12305191B2Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2024·Granted May 20, 2025·0 cites·26 claims
- 1286US8822410B2Tympanic membrane permeating ear drops and uses thereofSIMONS EMMANUEL JOHN·Filed 2009·Granted Sep 2, 2014·9 cites·11 claims
- 1384US12365726B2Anti-VEGF antibody constructsAKOUOS INC·Filed 2023·Granted Jul 22, 2025·0 cites·14 claims
- 1482US8658699B2Chemical permeation enhancers enhance nerve blockade by toxinsKOHANE DANIEL S·Filed 2009·Granted Feb 25, 2014·3 cites·23 claims
- 1577US2025297265A1Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2025·Application pending·0 cites
- 1677US2025313856A1Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2025·Application pending·0 cites
- 1774US2025263675A1Aav-mediated delivery of therapeutic antibodies to the inner earAKOUOS INC·Filed 2025·Application pending·0 cites
- 1873US2025223350A1Anti-vegf antibody constructs and related methods for treating vestibular schwannoma associated symptomsAKOUOS INC·Filed 2025·Application pending·0 cites
- 1973US2025223349A1Anti-vegf antibody constructs and related methods for treating vestibular schwannoma associated symptomsAKOUOS INC·Filed 2025·Application pending·0 cites
- 2072US2025041457A1Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner earAKOUOS INC·Filed 2024·Application pending·0 cites
- 2169US2021071149A1Aav-mediated delivery of therapeutic antibodies to the inner earAKOUOS INC·Filed 2018·Application pending·0 cites
- 2268US12226493B2Methods of treating non-syndromic sensorineural hearing lossAKOUOS INC·Filed 2019·Granted Feb 18, 2025·0 cites·15 claims
- 2367US2019185864A1Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2017·Application pending·0 cites
- 2463US2022040327A1Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2021·Application pending·0 cites
- 2563US2025136673A1Anti-vegf antibody constructs and related methods for treating vestibular schwannoma associated symptomsAKOUOS INC·Filed 2023·Application pending·0 cites
- 2662US2025288692A1Compositions and methods for treating kcnq4-associated hearing lossAKOUOS INC·Filed 2022·Application pending·0 cites
- 2760US2024167056A1Cell specific gene therapy delivery compositions and methods for treating hearing lossAKOUOS INC·Filed 2023·Application pending·0 cites
- 2860US2024252685A1Cell specific gene therapy delivery compositions and methods for treating hearing lossAKOUOS INC·Filed 2023·Application pending·0 cites
- 2958US2023212606A1Compositions and methods for treating kcnq4-associated hearing lossAKOUOS INC·Filed 2021·Application pending·0 cites
- 3058US2024139344A1Compositions and methods for treating clrn1-associated hearing loss and/or vision lossAKOUOS INC·Filed 2021·Application pending·0 cites
- 3158US2014080841A1Chemical Permeation Enhancers Enhance Nerve Blockade by ToxinsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 3256US2020390905A1Compositions and methods for treating non-age-associated hearing impairment in a human subjectAKOUOS INC·Filed 2019·Application pending·0 cites
- 3355US2023056182A1Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner earAKOUOS INC·Filed 2019·Application pending·0 cites
- 3455US2023201372A1Compositions and methods for treating slc26a4-associated hearing lossAKOUOS INC·Filed 2021·Application pending·0 cites
- 3555US2025339560A1Gene therapy delivery compositions and methods for treating hearing lossAKOUOS INC·Filed 2022·Application pending·0 cites
- 3651US2023183743A1Compositions and methods for treating gjb2-associated hearing lossAKOUOS INC·Filed 2021·Application pending·0 cites
- 3749US2021277417A1Methods of treating clrn1-associated hearing loss and/or vision lossAKOUOS INC·Filed 2019·Application pending·0 cites
- 3847US2022395582A1Compositions and methods of inducing differentiation of a hair cellAKOUOS INC·Filed 2019·Application pending·0 cites
- 3944US2022396806A1Methods of treating hearing loss using a secreted target proteinAKOUOS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emmanuel John Simons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →